Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
bexarotene retinoic acid receptor rxr-alpha small molecule Successful target TTD , drugbank , DGIDB Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Disease[MeSHID:D004194]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.57 approved,investigational agonist
bexarotene retinoic acid receptor rxr-alpha small molecule Successful target TTD , drugbank , DGIDB Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Disease[MeSHID:D004194]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.57 approved,investigational agonist,activator
bexarotene retinoic acid receptor rxr-beta small molecule NA drugbank , DGIDB Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Disease[MeSHID:D004194]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 11.32 approved,investigational agonist
bexarotene retinoic acid receptor rxr-beta small molecule NA drugbank , DGIDB Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Disease[MeSHID:D004194]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 11.32 approved,investigational agonist,activator
bexarotene retinoic acid receptor rxr-gamma small molecule NA drugbank , DGIDB Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Disease[MeSHID:D004194]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 11.14 approved,investigational agonist
bexarotene retinoic acid receptor rxr-gamma small molecule NA drugbank , DGIDB Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Disease[MeSHID:D004194]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 11.14 approved,investigational agonist,activator
click here to return to the previous page